Back

Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial fibrillation ablation and outcomes Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Mate Vamos

University of Szeged, Szeged (Hungary)

14 More presentations in this session

Presentation thumbnail
Associate Professor M. Samuel (Pittsburgh, US)
Abstract Slides
Presentation thumbnail
Doctor K. Nagaoka (Kurume, JP)
Abstract
Presentation thumbnail
Professor S. Han (Anyang-Si- Gyeonggi-Do, KR)
Abstract Slides
Presentation thumbnail
Associate Professor P. Yang (Seongnam, KR)
Abstract Slides
Presentation thumbnail
Assistant Professor E. Pagourelias (Thessaloniki, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Atrial fibrillation ablation and outcomes

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Presentation
AF-CARE: “R” Rate and rhythm control

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources